Kutshanje, abezindaba baphesheya kwelizwe iFierce Medtech ikhethe ezona zili-15 zintsha kakhuluiinkampani zezixhobo zonyangongo-2023. Ezi nkampani azijolisi nje kuphela kwiindawo zobugcisa eziqhelekileyo, kodwa zisebenzisa nengqiqo yazo ebukhali ukufumanisa ezinye iimfuno zonyango ezinokubakho.
01
Utyando lwe-Activ
Nika oogqirha botyando ulwazi olubonakalayo ngexesha langempela
I-CEO: uManisha Shah-Bugaj
Yasekwa: 2017
Ifumaneka e: eBoston
I-Activ Surgical igqibe utyando lokuqala lwerobhothi oluzenzekelayo kwihlabathi liphela kwizicubu ezithambileyo. Le nkampani ifumene imvume ye-FDA kwimveliso yayo yokuqala, i-ActivSight, imodyuli yotyando ehlaziya idatha yemifanekiso ngoko nangoko.
I-ActivSight isetyenziswa zizikhungo ezimalunga neshumi elinesibini eMelika kwiindlela zotyando lwe-colorectal, thoracic kunye ne-bariatric, kunye neenkqubo eziqhelekileyo ezifana nokususwa kwe-gallbladder. Ii-prostatectomies ezininzi zerobhothi nazo zenziwe kusetyenziswa i-ActivSight.
02
IiBionics zeBeta
Iipancreas zokwenziwa eziguqukayo
I-CEO: uSean Saint
Yasekwa: 2015
Indawo: Irvine, eCalifornia
Iinkqubo zokuhambisa i-insulin ezenzekelayo zixhaphakile kwihlabathi letekhnoloji yesifo seswekile. Le nkqubo, eyaziwa ngokuba yinkqubo ye-AID, yakhelwe kwi-algorithm ethatha ukufundwa kweglucose yegazi kwi-monitor yeglucose eqhubekayo, kunye nolwazi malunga nokutya kwe-carbohydrate kunye nomsebenzi womntu, kwaye iqikelela loo manqanaba kwimizuzu embalwa ezayo. utshintsho olunokwenzeka ngaphakathi kwepompo ye-insulin ngaphambi kokulungisa imveliso yepompo ye-insulin ukuze kuthintelwe i-hyperglycemia okanye i-hypoglycemia eqikelelweyo.
Le ndlela yobuchwepheshe obuphezulu idala inkqubo ebizwa ngokuba yi-hybrid closed-loop system, okanye i-pancreas yokwenziwa, eyenzelwe ukunciphisa umsebenzi wezandla kubantu abanesifo seswekile.
I-Beta Bionics ithatha eli nyathelo lihamba phambili ngetekhnoloji yayo ye-iLet bionic pancreas. Inkqubo ye-iLet ifuna kuphela ubunzima bomsebenzisi ukuba bufakwe, nto leyo esusa isidingo sokubala nzima ukutya iicarbohydrate.
03
Impilo yaseCala
Unyango olulodwa kuphela olunokunxitywa kwihlabathi liphela lokungcangcazela
OoSihlalo abancedisayo: uKate Rosenbluth, Ph.D., uDeanna Harshbarger
Yasekwa: 2014
Ifumaneka e: San Mateo, eCalifornia
Izigulana ezine-essential tremble (ET) bezisoloko zingenazo iindlela zonyango ezisebenzayo nezingenabungozi. Izigulana zinokwenza utyando lobuchopho oluhlaselayo kuphela ukuze kufakwe isixhobo sokuvuselela ubuchopho esinzulu, rhoqo sineziphumo eziphantsi, okanye amayeza ambalwa anyanga kuphela iimpawu kodwa kungekhona unobangela oyintloko, kwaye anokubangela iziphumo ebezingalindelekanga ezibi kakhulu.
Inkampani entsha yeSilicon Valley, iCala Health, iphuhlise isixhobo esinxitywayo sokungcangcazela okubalulekileyo esinokunika unyango lwe-neuromodulation ngaphandle kokuphula ulusu.
Isixhobo senkampani iCala ONE savunywa okokuqala yi-FDA ngo-2018 ukuze sinyange kuphela i-essential tremor. Ehlotyeni elidlulileyo, iCala ONE yaqalisa inkqubo yayo yesizukulwana esilandelayo nge-510(k) clearance: iCala kIQ™, isixhobo sokuqala nesikuphela kwaso esivunyiweyo yi-FDA esibonelela ngonyango olusebenzayo lwezandla kwizigulana ezine-essential tremor kunye nesifo sikaParkinson. Isixhobo esinokunxitywa sonyango lokunciphisa i-tremor.
04
Isizathu
Ukuguqula uPhando lwezonyango
I-CEO: Yiannis Kiachopoulos
Yasekwa: 2018
Ifumaneka e: eLondon
UCausaly uphuhlise oko uKiachopoulos akubiza ngokuba “ngumqhubi we-AI oncedisayo wenqanaba lokuqala lemveliso” ovumela izazinzulu ukuba zikhawulezise ukukhangela ulwazi. Izixhobo ze-AI ziya kuphanda lonke uphando olushicilelweyo lwezonyango kwaye zinike iimpendulo ezipheleleyo kwimibuzo enzima. Oku kunceda iinkampani eziphuhlisa amayeza ukuba zibe nokuzithemba ngakumbi kwiindlela abazenzayo, njengoko abathengi besazi ukuba esi sixhobo siya kunika ulwazi olupheleleyo malunga nendawo yesifo okanye iteknoloji.
Into eyahlukileyo ngeCausaly kukuba nabani na angayisebenzisa, kwanabo bangengobantu.
Eyona nto ingcono kukuba, abasebenzisi akufuneki bazifundele zonke iixwebhu ngokwabo.
Enye inzuzo yokusebenzisa iCausaly kukuchonga iziphumo ebezingalindelekanga ukuze iinkampani zikwazi ukususa iithagethi.
05
IiSayensi zebhayoloji zeElement
Cela umngeni kunxantathu ongenakwenzeka womgangatho, iindleko kunye nokusebenza kakuhle
I-CEO: Molly He
Yasekwa: 2017
Ifumaneka e: San Diego
Inkqubo ye-Aviti yenkampani iza kuqala ukusebenza ekuqaleni kowama-2022. Njengesixhobo esilingana nedesktop, ineeseli ezimbini zokuhamba ezinokusebenza ngokuzimeleyo, nto leyo enciphisa kakhulu iindleko zokulandelelana. I-Aviti24, ekulindeleke ukuba iqale ukusebenza kwisiqingatha sesibini salo nyaka, yenzelwe ukubonelela ngohlaziyo kwiimashini ezifakwe ngoku kwaye ziguqule zibe ziiseti zehardware ezikwaziyo ukuhlalutya kungekuphela nje i-DNA kunye ne-RNA, kodwa kunye neeproteni kunye nolawulo lwazo, kunye nemo yeeseli.
06
Nika amandla ii-Injections
Ukulawulwa ngemithambo nangaliphi na ixesha, naphi na
I-CEO: uMike Hooven
Yasekwa: 2010
Ifumaneka eCincinnati
Njengenkampani yezobuchwepheshe bezonyango esele ineminyaka engaphezu kweshumi isenziwa, i-Enable Injections yenza inkqubela kutshanje.
Kule ntwasahlobo, inkampani ifumene isixhobo sayo sokuqala esivunyiweyo yi-FDA, isixhobo esifakwa inaliti se-EMPAVELI, esine-Pegcetacoplan, unyango lokuqala olujoliswe kwi-C3 ukunyanga i-PNH (i-paroxysmal nocturnal hemoglobinuria). I-Pegcetacoplan lolona nyango lokuqala oluvunyiweyo yi-FDA ngo-2021. Unyango olujoliswe kwi-C3 lokunyanga i-PNH lukwalo nyango lokuqala oluvunyiweyo kwihlabathi ukunyanga i-macular geographic atrophy.
Imvume le yimbangela yomsebenzi weminyaka emininzi owenziwa yile nkampani kwizixhobo zokuhambisa amayeza ezenzelwe ukuba zibe lula kumonde ngelixa zivumela ukunikezelwa kweedosi ezinkulu ngemithambo yegazi.
07
I-Exo
Ixesha elitsha le-ultrasound ephathwayo
I-CEO: u-andeep Akkaraju
Yasekwa: 2015
Ifumaneka e: Santa Clara, eCalifornia
I-Exo Iris, isixhobo se-ultrasound esiphathwa ngesandla esasungulwa yi-Exo ngoSeptemba 2023, sadunyiswa “njengexesha elitsha le-ultrasound” ngelo xesha, kwaye sathelekiswa nee-probes eziphathwa ngesandla ezivela kwiinkampani ezifana ne-GE Healthcare kunye ne-Butterfly Network.
I-Iris probe ephathwa ngesandla ithatha imifanekiso enombono we-150-degree, ethi le nkampani inokugubungela isibindi sonke okanye usana olungekazalwa lonke ukuya kutsho kwiisentimitha ezingama-30. Ungatshintsha phakathi kwe-curved, linear okanye phased array, ngelixa iinkqubo ze-ultrasound zemveli zihlala zifuna ii-probe ezahlukeneyo.
08
Unyango lweGenesis
Inkwenkwezi Ekhulayo Yezamayeza ze-AI
I-CEO: Evan Feinberg
Yasekwa: 2019
Ifumaneka e: Palo Alto, eCalifornia
Ukubandakanya ukufunda koomatshini kunye nobukrelekrele bokwenziwa kuphuhliso lwamayeza yindawo enkulu yotyalo-mali kwishishini le-biopharmaceutical.
IGenesis ijonge ukwenza oku ngeqonga layo le-GEMS, isebenzisa inkqubo entsha eyakhiwe ngabaseki benkampani ukuyila iimolekyuli ezincinci, endaweni yokuxhomekeka kwiinkqubo zoyilo ezingezizo iikhemikhali ezikhoyo.
Iqonga leGenesis Therapeutics' GEMS (Genesis Exploration of Molecular Space) lidibanisa iimodeli zokuqikelela ezisekelwe ekufundeni okunzulu, ukulinganisa iimolekyuli kunye neemodeli zolwimi zokuqonda iikhemikhali, linethemba lokudala amayeza amancinci emolekyuli "aphambili" anamandla aphezulu kakhulu kunye nokukhetha. , ingakumbi ekujoliseni iinjongo ezazingenakusetyenziswa ngaphambili.
09
Ukuhamba kwentliziyo
Inkokeli ye-FFR
I-CEO: uJohn Farquhar
Yasekwa: 2010
Ifumaneka e: Mountain View, eCalifornia
I-HeartFlow ikhokela kwi-Fractional Flow Reserve (FFR), inkqubo ehlola i-3D CT angiography scans yentliziyo ukuze ichonge i-plaque kunye nokuvaleka kwimithambo yentliziyo.
Ngokubonelela ngembonakalo yokuhamba kwegazi elineoksijini ukuya kwimisipha yentliziyo kunye nokulinganisa ngokucacileyo iindawo zemithambo yegazi exineneyo, inkampani imisele indlela eyenzelwe wena yokungenelela kwiimeko ezifihlakeleyo ezibangela amashumi ezigidi zeentlungu zesifuba kunye nokuhlaselwa yintliziyo minyaka le. Izizathu ezibangela amatyala okuxhuzula.
Injongo yethu ephambili kukwenza oko sikwenzayo kwisifo sentliziyo ngokuhlola umhlaza kwangethuba kunye nonyango olulungiselelwe wena, ukunceda oogqirha benze izigqibo ezisekelwe kwiimfuno zesigulana ngasinye.
10
Karius
Yilwa nezifo ezingaziwayo
I-CEO: u-Alec Ford
Yasekwa: 2014
Ifumaneka eRedwood City, eCalifornia
Uvavanyo lweKarius lubuchwepheshe obutsha bokuxilonga ngolwelo obunokubona iintsholongwane ezingaphezu kwe-1,000 ezisulelayo kwigazi elinye kwiiyure ezingama-26. Olu vavanyo lunokunceda oogqirha ukuba baphephe ukuxilongwa okungafunekiyo, banciphise amaxesha okubuyela esiqhelweni, kwaye baphephe ukulibaziseka ekunyangeni izigulana ezilaliswe esibhedlele.
11
I-Linus Biotechnology
Iinwele ze-1cm zokuxilonga i-autism
I-CEO: UGqr. Manish Arora
Yasekwa: 2021
Ifumaneka eNorth Brunswick, eNew Jersey
I-StrandDx ingakhawulezisa inkqubo yovavanyo ngekhithi yovavanyo yasekhaya efuna nje intambo yeenwele ukuba ithunyelwe kwinkampani ukuze kuchongwe ukuba i-autism ayinakuthintelwa na.
12
Ilebhu yaseNamida
Isikrini seenyembezi somhlaza webele
I-CEO: u-Omid Moghadam
Yasekwa: 2019
Ifumaneka eFayetteville, eArkansas
I-Auria luvavanyo lokuqala lokuhlola umhlaza webele oluqhutywa ekhaya olusebenzisa iinyembezi, olungeyondlela yokuxilonga kuba aluniki ziphumo zimbini ezixelayo ukuba umhlaza webele ukhona na. Endaweni yoko, yahlulahlula iziphumo zahlulwe zibe ngamacandelo amathathu ngokusekelwe kumanqanaba ee-biomarkers ezimbini zeproteni kwaye icebisa ukuba umntu kufuneka afune uqinisekiso olongezelelweyo kwi-mammogram ngokukhawuleza.
13
UNowa wezonyango
i-biopsy yemiphunga i-nova
CEO: Zhang Jian
Yasekwa: 2018
Ifumaneka e: San Carlos, eCalifornia
I-Noah Medical iqokelele i-$150 yezigidi kunyaka ophelileyo ukunceda inkqubo yayo ye-bronchoscopy ekhokelwa yi-Galaxy ikhuphisane nezikhulu ezimbini zoshishino, iqonga le-Ion le-Intuitive Surgical kunye ne-Monarch kaJohnson & Johnson.
Zonke ezi zixhobo zintathu zenzelwe ukuba zibe yiprobe encinci efaka i-bronchi kunye neendlela zokungena ngaphandle kwemiphunga, inceda oogqirha botyando ukuba bakhangele izilonda kunye namaqhuqhuva ekucingelwa ukuba afihla iithumba ezinomhlaza. Nangona kunjalo, uNoah, njengomntu ofike emva kwexesha, wafumana imvume ye-FDA ngoMatshi 2023.
NgoJanuwari kulo nyaka, inkqubo yeGalaxy yenkampani igqibe itshekhi yayo yama-500.
Into entle ngoNoah kukuba le nkqubo isebenzisa izinto ezingasetyenziswayo ngokupheleleyo, kwaye yonke into edibana nesigulana ingalahlwa kwaye ithathelwe indawo zizixhobo ezintsha.
14
I-Procyrion
Ukuthintela unyango lwezifo zentliziyo nezintso
Igosa eliyiNtloko: u-Eric Fain, MD
Yasekwa: 2005
Ifumaneka e: eHouston
Kwabanye abantu abanesifo sentliziyo, kwenzeka i-feedback loop ebizwa ngokuba yi-cardiorenal syndrome, apho izihlunu zentliziyo ezibuthathaka ziqala ukuncipha ekukwazini kwazo ukususa ulwelo emzimbeni xa izihlunu zentliziyo ezibuthathaka zingakwazi ukuthwala igazi kunye neoksijini ukuya ezintso. Oku kuqokelelana kolwelo, ngakolunye uhlangothi, kwandisa ubunzima bokubetha kwentliziyo.
I-Procyrion ijonge ukuphazamisa le mpendulo nge-Aortix pump, isixhobo esincinci, esisekelwe kwi-catheter esingena kwi-aorta yomzimba ngesikhumba size sehle ngesifuba nesisu.
Ifana kakhulu nezinye iimpompo zentliziyo ezisekelwe kwi-impeller, ukuyibeka phakathi kwenye yezona mithambo-luvo zikhulu zomzimba ngaxeshanye kunciphisa umthwalo womsebenzi entliziyweni ephezulu kwaye kunceda ukuhamba kwegazi okuya kwizintso.
15
Iproprio
Yenza imephu yotyando
I-CEO: uGabriel Jones
Yasekwa: 2016
Ifumaneka e: Seattle
I-Paradigm, inkampani yeProprio, liqonga lokuqala lokusebenzisa iteknoloji ye-light field kunye nobukrelekrele bokwenziwa ukuvelisa imifanekiso ye-3D yexesha langempela ye-anatomy yesigulana ngexesha lotyando ukuxhasa utyando lomqolo.
Ixesha leposi: Matshi-28-2024